Stock Events

Quest Diagnostics 

€131.8
157
+€2.35+1.82% Friday 06:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
15.6B
P/E Ratio
18.53
Dividend Yield
2.09%
Dividend
2.75

Upcoming

Dividends

2.09%Dividend Yield
10Y Growth
8.66%
5Y Growth
6.9%
3Y Growth
6.94%
1Y Growth
6.09%

Earnings

23JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
1.86
2.02
2.17
2.33
Expected EPS
2.33
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QDI.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap0
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap7.93B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap209.21B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap182.73B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap36.87B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap3.52B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Exact Sciences
EXAS
Mkt Cap8.22B
Exact Sciences Corporation is known for its non-invasive screening test for colorectal cancer, competing in the diagnostics market.
Neogenomics
NEO
Mkt Cap1.73B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap2.25B
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

Analyst Ratings

150.89Average Price Target
The highest estimate is €165.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

About

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Show more...
CEO
Mr. James E. Davis
Employees
50000
Country
US
ISIN
US74834L1008
WKN
000904533

Listings